Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Affibody molecules: potential for<i>in vivo</i>imaging of molecular targets for cancer therapy

21 Mar 2007

Abstract excerpt

Targeting radionuclide imaging of tumor-associated antigens may help to select patients who will benefit from a particular biological therapy. Affibody molecules are a novel class of small (approximately 7 kDa) phage display-selected affinity proteins, based on the B-domain scaffold of staphylococcal protein A. A large library (3 x 10(9) variants) has enabled selection of high-affinity (up to 22 pM) binders for a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17373906
DOI: 10.1517/14712598.7.4.555

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Affibody molecules: potential for<i>in vivo</i>imaging of molecular targets for cancer therapyPMID 17373906Read ↗

Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody moleculesSemantic proximity Read ↗

Antibody Phage Display Libraries: Contributions to OncologySemantic proximity Read ↗

In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery propertiesSemantic proximity Read ↗

Phage display for discovery of anticancer antibodiesSemantic proximity Read ↗

Peptide Phage Display: Opportunities for Development of Personalized Anti-Cancer StrategiesSemantic proximity Read ↗

High affinity nanobodies against human epidermal growth factor receptor selected on cells by<i>E. coli</i>displaySemantic proximity Read ↗

Targeting the ITGA3B1 Complex with A Novel Antibody-Drug Conjugate for Metastatic Bladder CancerSemantic proximity Read ↗

Progress on Phage Display Technology: Tailoring Antibodies for Cancer ImmunotherapySemantic proximity Read ↗

Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical ApplicationsSemantic proximity Read ↗

De novo identification of tumor-specific internalizing human antibody–receptor pairs by phage-display methodsSemantic proximity Read ↗

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivoSemantic proximity Read ↗

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.